OncoSec Medical Inc (ONCSQ)

[lasers]

Strange as it is, OncoSec is far more advanced than Inovio when it comes to clinical trials for cancer treatment with both its NeoPulse and ImmunoPulse. The Inovio-Roche deal is primarily for R&D. OncoSec Bleomycin has been Commercially approved by the EMA throughout Europe. It has successfully been approved to be equal to surgery for Breast Cancer. This would also mean Prostate Cancer. There would be no need for surgical removal.

Yes what is good for Inovio is good for OncoSec. They do cross-license their Patented Electroporation devices.